Cargando…
Bicyclic 1-Hydroxy-2-oxo-1,2-dihydropyridine-3-carboxamide-Containing HIV-1 Integrase Inhibitors Having High Antiviral Potency against Cells Harboring Raltegravir-Resistant Integrase Mutants
[Image: see text] Integrase (IN) inhibitors are the newest class of antiretroviral agents developed for the treatment of HIV-1 infections. Merck’s Raltegravir (RAL) (October 2007) and Gilead’s Elvitegravir (EVG) (August 2012), which act as IN strand transfer inhibitors (INSTIs), were the first anti-...
Autores principales: | Zhao, Xue Zhi, Smith, Steven J., Métifiot, Mathieu, Johnson, Barry C., Marchand, Christophe, Pommier, Yves, Hughes, Stephen H., Burke, Terrence R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American
Chemical
Society
2014
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3983366/ https://www.ncbi.nlm.nih.gov/pubmed/24471816 http://dx.doi.org/10.1021/jm401902n |
Ejemplares similares
-
4-Amino-1-hydroxy-2-oxo-1,8-naphthyridine-Containing
Compounds Having High Potency against Raltegravir-Resistant Integrase
Mutants of HIV-1
por: Zhao, Xue Zhi, et al.
Publicado: (2014) -
Correction to 4-Amino-1-hydroxy-2-oxo-1,8-naphthyridine-Containing
Compounds Having High Potency against Raltegravir-Resistant Integrase
Mutants of HIV-1
por: Zhao, Xue Zhi, et al.
Publicado: (2014) -
Resistance to Integrase Inhibitors
por: Métifiot, Mathieu, et al.
Publicado: (2010) -
HIV-1 Integrase Strand Transfer Inhibitors
with Reduced Susceptibility to Drug Resistant Mutant Integrases
por: Zhao, Xue Zhi, et al.
Publicado: (2016) -
HIV-1 Integrase Inhibitors with Modifications
That Affect Their Potencies against Drug Resistant Integrase Mutants
por: Smith, Steven J., et al.
Publicado: (2021)